Skip to main content
Search
Home / ‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease

‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease

While this new treatment is “helpful” in some ways, “this is certainly not going to be the silver bullet that is going to resolve the issues of dementia,” said Dr. Samir Sinha, Sinha, director of health policy research at the National Institute on Ageing.

Globe and Mail Logo

Contributors